55403-26-4 Usage
Uses
Used in Pharmaceutical Synthesis:
3-Chloro-4-piperidin-1-yl-phenylamine is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new therapeutic agents. Its unique structure allows for the creation of diverse medicinal compounds with potential applications in treating a range of health conditions.
Used in Agrochemical Production:
In the agrochemical industry, 3-Chloro-4-piperidin-1-yl-phenylamine is employed as a crucial component in the formulation of various agrochemicals. Its incorporation aids in enhancing the effectiveness of these products, contributing to improved agricultural practices and crop protection.
Used in Chemical Research:
3-Chloro-4-piperidin-1-yl-phenylamine is utilized as a valuable research tool in chemical research, particularly for studying its biological activities and exploring its potential as a building block for new compounds. This research can lead to advancements in the discovery of novel therapeutic agents and the enhancement of existing pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 55403-26-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,4,0 and 3 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 55403-26:
(7*5)+(6*5)+(5*4)+(4*0)+(3*3)+(2*2)+(1*6)=104
104 % 10 = 4
So 55403-26-4 is a valid CAS Registry Number.
55403-26-4Relevant academic research and scientific papers
GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE
-
Paragraph 001142; 001146; 001831; 001832, (2021/01/22)
Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with a defect in glyoxylate metabolism, for example a disease or disorder associated with the enzyme glycolate oxidase (GO) or alterations in oxalate metabolism. Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.
N-(3,4-disubstituted phenyl) salicylamide derivatives
-
Page/Page column 50, (2008/12/07)
A compound represented by the following formula (I) or a salt thereof: wherein R1, R2, R3 and R4 represent hydrogen atom, a halogen atom, cyano group, nitro group, a C1-4 alkyl group, a halogenated C
9-(P-phenylazoanilino)-7-methyl-1H-imidazo[4,5-f]quinolines
-
, (2008/06/13)
A series of 9-(substituted amino)imidazo[4,5-f]quinolines are effective anthelmintic agents; particularly in respect to the tapeworm Hymenolepis nana.
